title: Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.
abstract: Prospective studies continue to identify malaria parasite genes with particular patterns of polymorphism which indicate they may be under immune selection, and the encoded proteins require investigation. Sixteen new recombinant protein reagents were designed to characterize three such polymorphic proteins expressed in Plasmodium falciparum schizonts and merozoites: MSPDBL1 (also termed MSP3.4) and MSPDBL2 (MSP3.8), which possess Duffy binding-like (DBL) domains, and SURFIN4.2, encoded by a member of the surface-associated interspersed (surf) multigene family. After testing the antigenicities of these reagents by murine immunization and parasite immunofluorescence, we analyzed naturally acquired antibody responses to the antigens in two cohorts in coastal Kenya in which the parasite was endemic (Chonyi [n = 497] and Ngerenya [n = 461]). As expected, the prevalence and levels of serum antibodies increased with age. We then investigated correlations with subsequent risk of clinical malaria among children <11 years of age during 6 months follow-up surveillance. Antibodies to the polymorphic central region of MSPDBL2 were associated with reduced risk of malaria in both cohorts, with statistical significance remaining for the 3D7 allelic type after adjustment for individuals' ages in years and antibody reactivity to whole-schizont extract (Chonyi, risk ratio, 0.51, and 95% confidence interval [CI], 0.28 to 0.93; Ngerenya, risk ratio, 0.38, and 95% CI, 0.18 to 0.82). For the MSPDBL1 Palo Alto allelic-type antigen, there was a protective association in one cohort (Ngerenya, risk ratio, 0.53, and 95% CI, 0.32 to 0.89), whereas the other antigens showed no protective associations after adjustment. These findings support the prediction that antibodies to the polymorphic region of MSPDBL2 contribute to protective immunity.
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Kevin K A
authors.initials: KK
authors.lastname: Tetteh
authors.forename: Faith H A
authors.initials: FH
authors.lastname: Osier
authors.forename: Ali
authors.initials: A
authors.lastname: Salanti
authors.forename: Gathoni
authors.initials: G
authors.lastname: Kamuyu
authors.forename: Laura
authors.initials: L
authors.lastname: Drought
authors.forename: Marilyne
authors.initials: M
authors.lastname: Failly
authors.forename: Christophe
authors.initials: C
authors.lastname: Martin
authors.forename: Kevin
authors.initials: K
authors.lastname: Marsh
authors.forename: David J
authors.initials: DJ
authors.lastname: Conway
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology / Q000378:metabolism*; D000953:Antigens, Protozoan / Q000276:immunology / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D000939:Epitopes; D006801:Humans; D007223:Infant; D052940:Merozoites / Q000378:metabolism*; D051379:Mice; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000235:genetics / Q000378:metabolism*; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D011994:Recombinant Proteins; D055815:Young Adult
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D000939:Epitopes; D015800:Protozoan Proteins; D011994:Recombinant Proteins
references.citation: Hum Vaccin. 2010 Jan;6(1):39-53
references.pmid: 20061790
references.citation: Vaccine. 2013 Apr 18;31 Suppl 2:B233-43
references.pmid: 23598488
references.citation: PLoS One. 2009;4(4):e5410
references.pmid: 19404387
references.citation: Int J Parasitol. 2009 Jun;39(7):763-73
references.pmid: 19367830
references.citation: Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
references.pmid: 19136431
references.citation: Mol Biochem Parasitol. 2004 Sep;137(1):13-21
references.pmid: 15279947
references.citation: PLoS One. 2011;6(10):e26616
references.pmid: 22073118
references.citation: PLoS Pathog. 2006 Nov;2(11):e124
references.pmid: 17112315
references.citation: PLoS Med. 2010 Jul 06;7(7):e1000304
references.pmid: 20625549
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13052-7
references.pmid: 22826220
references.citation: Bioinformatics. 2007 Nov 1;23(21):2947-8
references.pmid: 17846036
references.citation: Infect Immun. 2013 May;81(5):1491-501
references.pmid: 23429537
references.citation: J Infect Dis. 2007 Jan 15;195(2):279-87
references.pmid: 17191173
references.citation: Science. 2003 Sep 12;301(5639):1503-8
references.pmid: 12893887
references.citation: PLoS One. 2012;7(12):e51023
references.pmid: 23227229
references.citation: Nature. 2002 Oct 3;419(6906):520-6
references.pmid: 12368866
references.citation: Curr Genomics. 2010 Jun;11(4):279-86
references.pmid: 21119892
references.citation: Infect Immun. 2010 Jan;78(1):486-94
references.pmid: 19884337
references.citation: Infect Immun. 2008 May;76(5):2240-8
references.pmid: 18316390
references.citation: PLoS Genet. 2011 Apr;7(4):e1001383
references.pmid: 21533027
references.citation: Nature. 2011 Nov 09;480(7378):534-7
references.pmid: 22080952
references.citation: PLoS Genet. 2012;8(11):e1002992
references.pmid: 23133397
references.citation: Nat Genet. 2007 Jan;39(1):126-30
references.pmid: 17159981
references.citation: Mol Biol Evol. 2010 Oct;27(10):2344-51
references.pmid: 20457586
references.citation: J Biol Chem. 2012 Sep 21;287(39):32922-39
references.pmid: 22843685
references.citation: J Infect Dis. 2005 Jun 1;191(11):1932-9
references.pmid: 15871128
references.citation: Nature. 2012 Jul 19;487(7407):375-9
references.pmid: 22722859
references.citation: Parasite Immunol. 2012 Feb-Mar;34(2-3):50-60
references.pmid: 21995286
references.citation: PLoS Med. 2010 Jan 19;7(1):e1000218
references.pmid: 20098724
references.citation: Vaccine. 2004 Dec 16;23(5):718-28
references.pmid: 15542195
references.citation: Vaccine. 2006 May 8;24(19):4233-46
references.pmid: 16111789
references.citation: Nat Med. 2000 Jun;6(6):689-92
references.pmid: 10835687
references.citation: Clin Vaccine Immunol. 2012 Jan;19(1):30-6
references.pmid: 22116684
references.citation: Clin Chem. 2007 Jul;53(7):1244-53
references.pmid: 17510307
references.citation: PLoS One. 2009;4(5):e5568
references.pmid: 19440377
references.citation: PLoS Biol. 2003 Oct;1(1):E5
references.pmid: 12929205
references.citation: Infect Immun. 2003 Apr;71(4):1833-42
references.pmid: 12654798
references.citation: J Exp Med. 2005 Jun 6;201(11):1853-63
references.pmid: 15939796
references.citation: Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9
references.pmid: 20439314
references.citation: Vaccine. 2011 Oct 13;29(44):7811-7
references.pmid: 21820475
references.citation: Antimicrob Agents Chemother. 2013 Jul;57(7):2937-41
references.pmid: 23587962
references.citation: PLoS One. 2009 Dec 01;4(12):e8110
references.pmid: 19956619
references.citation: Parasitol Int. 2011 Sep;60(3):313-20
references.pmid: 21616162